Drospirenone is one of the least likely hormonal contraceptive progestins to cause weight gain. In clinical trials for Yaz (drospirenone with ethinyl estradiol), only 2.5% of users reported increased weight as a side effect. For the progestin-only pill Slynd, weight gain led to discontinuation in just 0.3% to 1.2% of participants. Some users actually lose a small amount of weight on drospirenone, thanks to a unique property that sets it apart from other progestins.
Why Drospirenone Differs From Other Progestins
Most progestins used in birth control have no effect on fluid balance, which means they don’t counteract the water retention that estrogen promotes. Drospirenone works differently. It blocks aldosterone, a hormone your body uses to signal your kidneys to hold onto sodium and water. This anti-aldosterone effect is comparable to what your body naturally does during the second half of your menstrual cycle, when progesterone levels rise and you excrete more sodium.
A 3 mg dose of drospirenone has roughly the same fluid-balancing power as 20 to 25 mg of spironolactone, a prescription diuretic. That’s a meaningful effect. It actively counteracts the tendency of estrogen-containing pills to cause bloating and water retention, which is one of the main reasons people associate birth control with weight gain in the first place.
What the Clinical Data Shows
In head-to-head comparisons with levonorgestrel (one of the most widely used progestins), drospirenone users were consistently less likely to gain more than 2 kg over six cycles. A Cochrane systematic review found that drospirenone users were also significantly more likely to lose more than 2 kg compared to levonorgestrel users, with about nine times the odds of losing that amount when a low-dose estrogen formulation was used.
Longer-term data tells a similar story. In studies lasting a year or more, women taking drospirenone-containing pills maintained a stable body weight or experienced a slight decrease. One year-long study found an average weight loss of 1.2 kg among drospirenone users. By comparison, those taking estrogen without drospirenone tended to gain weight over the same period. In studies spanning 13 to 26 cycles, mean body weight stayed below baseline for the majority of drospirenone users.
Metabolic Effects Beyond Water Weight
Weight concerns with hormonal contraceptives aren’t limited to fluid retention. Some progestins can worsen insulin resistance or shift how your body processes fat, which could promote genuine fat gain over time. Drospirenone doesn’t appear to do this. Studies measuring blood sugar and insulin levels found that drospirenone had a neutral effect on carbohydrate metabolism and did not impair insulin sensitivity. After six months of use, insulin levels actually decreased slightly.
Cholesterol markers also moved in a favorable direction, with total cholesterol and LDL (“bad” cholesterol) dropping after three and six months. HDL cholesterol and triglycerides stayed stable. These metabolic findings suggest that drospirenone doesn’t create the kind of hormonal environment that promotes fat storage.
Some People Do Gain Weight
Despite the favorable averages, a small percentage of users will gain weight on drospirenone. The 2.5% rate reported in clinical trials is real, and individual responses to any hormonal medication vary. Hormonal contraceptives can affect appetite, mood, and energy levels in ways that indirectly influence eating habits and activity, and those effects are harder to capture in studies that only track the number on a scale.
If you’ve gained weight on other birth control pills in the past, drospirenone is worth considering as an alternative. Its diuretic properties specifically target the bloating and puffiness that many people notice in the first few months on a new pill. But it’s not a guarantee. The weight changes seen in studies are averages, and your experience could fall on either side.
Combined Pill vs. Progestin-Only Pill
Drospirenone is available in two main forms: combined with estrogen (as in Yaz or Yasmin) or as a progestin-only pill (Slynd). The weight profile is favorable for both, but they work slightly differently. In the combined pill, drospirenone’s anti-aldosterone effect directly counteracts the water retention caused by the estrogen component. The progestin-only version doesn’t include estrogen, so there’s less fluid retention to counteract in the first place.
In adolescent trials of Slynd, weight gain wasn’t even listed among the reasons patients stopped taking the pill. The most common reasons for discontinuation were irregular bleeding and acne, not weight changes. For adults on Slynd, increased weight was a discontinuation reason for no more than 1.2% of participants, making it one of the least common complaints.